
In a "low mitigation" scenario, work requirements and redetermination every six months would mean a 55% decline in projected 2028 Medicaid enrollment, from 18.4 million to 8.3 million.

Peter Wehrwein has been the lead editor of Managed Healthcare Executive since February 2020.

In a "low mitigation" scenario, work requirements and redetermination every six months would mean a 55% decline in projected 2028 Medicaid enrollment, from 18.4 million to 8.3 million.

Results of a study done at Cedars-Sinai Medical Center in Los Angeles and Brigham and Women's Hospital in Boston suggest that older patients with low medication adherence and literacy might benefit from a pharmacist-led medication management as they are leaving the hospital.

Pharmacists have the training and are employed by the health system so it makes sense to put them in charge of postdischarge medication planning and management

Joshua M. Pevnick, M.D., M.S.H.S., discusses medications and the risk of an adverse drug event among older people after they get discharged from the hospital.


Results of a pragmatic clinical trial showed no statistical difference between a pharmacist-led intervention and usual care when it comes to hospital utilization. The results suggest targeting such efforts at a narrower group of patients with low medication adherence and literacy might be more effective.

Advocate Health, Tenet Health, Mass General Brigham, Trinity Health and the Mayo Clinic are among the hospital and health system organizations that spent more than $1 million on federal government lobbying in 2024, according to study published in JAMA Health Forum.

Utah's Office of Artificial Intelligence Policy has approved demonstration projects testing AI for prescription drug renewals and certain dental diagnoses.

Demonstration projects testing AI for prescription renewals and certain dental diagnoses have been approved by Utah's Office of Artificial Intelligence Policy.

The state of Oregon has a commitment to keeping people covered and created a bridge program that extended Medicaid eligibility, Hunter noted.

Shorter hospital stays are a "good barometer" for quality and patient experience, says Risant Health CEO Jaewon Ryu.

The need for translation and navigation services — the staffing to support them has increased, says Hunter, particularly in immigration communities.


The costs are high, and the care system is designed for episodic intervention, “but then what happens?" asks Hunter.

Employers are bypassing insurers and contracting directly with providers. Direct contracting is not new, but soaring healthcare costs and the weight of fiduciary responsibility are whetting employers’ appetites for this option.


Risant Health comprises Geisinger Health in Pennsylvania and Cone Health in North Carolina. Risant CEO Jaewon Ryu, M.D., J.D., discussed how the two systems are prime candidates for adopting value-based care practices


During the first part of a wide-ranging interview with MHE, Hunter discussed behavioral health and financial pressures on the Medicaid managed care plna he runs in Oregon.

Jaewon Ryu, M.D., J.D., sees prevention and early recognition of disease as central to value-based care practices and programs at health systems.

Jaewon Ryu, M.D., J.D., CEO of Risant Health, discusses the role of accountable care organizations in supporting value-based practices at health systems.

Lindsay Greenleaf, J.D., MBA, and Nicolas Ferreyros offered insight and analysis during a March 3 webinar about healthcare policy and politics.

The first patient was enrolled in a trial of the inhaled insulin product for older children and adolescents who have been recently diagnosed with Type 1 diabetes.

In the first segment of a video interview with MHE, the CEO of Risant Health discusses the role of scale in following value-based practices.

Risant’s CEO, Jaewon Ryu, M.D., J.D., discusses some of the early successes of bringing a set of Kaiser Permanente’s value-based care practices to Risant's health systems—Geisinger Health in Pennsylvania and Cone Health in North Carolina. Consistency and "systemness” are key.

By accommodating the Trump administration's most favored nation drug pricing agenda, the pharmaceutical industry has avoided tariffs and seems likely to do so after the Supreme Court ruling last week.

The role of the pharmacist, managed care pharmacist job satisfaction and artificial intelligence were among the topics that Susan A. Cantrell, CEO of the Academy of Managed Care Pharmacy, discussed with Perry Cohen, Pharm.D., in this episode of "Conversations with Perry and Friends."

The deals that drugmakers have struck in response to Trump's most favored nation pricing policies may not be affected, partly because the president has authority to impose tariffs under other statutes.

And amid the ads for Pringles, Pepsi and Ritz crackers, boxer Mike Tyson appears in a MAHA ad inveighing against processed foods.

PBM reform has finally made its way through Congress and was signed into law by President Donald Trump. Here are seven things you need to know about the law.